A Study of FF-10501-01 in Combination with Azacitidine in Patients with Myelodysplastic Syndrome

NCT03486353 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Program terminated

Conditions

Myelodysplastic Syndrome (MDS)

Interventions

DRUG: FF-10501-01
DRUG: Azacitidine

Sponsor

Fujifilm Pharmaceuticals U.S.A., Inc.